Cardiac amyloidosis: updates in diagnosis and management.
about
Sarcoidosis and the heart: A review of the literature.Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosisRecurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib.Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatmentCardiac amyloidosis in a heart transplant patient - A case report and retrospective analysis of amyloidosis evolution.Hypertension is associated with preamyloid oligomers in human atrium: a missing link in atrial pathophysiology?Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: Case report.Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisPathophysiology and treatment of cardiac amyloidosis.Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.Comprehensive review on cardio-oncology: Role of multimodality imaging.Recent advances in the noninvasive strategies of cardiac amyloidosis.Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac responseThe role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.Prognostic value of right ventricular systolic function in cardiac amyloidosis.Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma.Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy.Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational studyLight-chain cardiac amyloidosis with neuropathy: a case report.Bladder perforation secondary to primary systemic amyloidosis.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.Dysproteinemias and Glomerular Disease.Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.Cardiac amyloidosis is associated with increased aortic stiffness.Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses.Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.Acromegaly-induced cardiomyopathy with dobutamine-induced outflow tract obstruction.Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosisThree-dimensional Speckle Tracking Echocardiography in Amyloidosis: A New Assessment Method for a Rare Disease
P2860
Q26775782-B9579FEC-32EB-4666-8F60-4B9B4A1A2221Q28069975-463A9264-4D74-43C9-A7EE-34A79B3940D7Q30377076-DAE6CF69-EE66-4584-9062-24CD748E96C4Q34617313-73C98240-69AF-4490-829C-770C61EBE7D2Q35066592-ECFA22B6-D460-41F4-9D63-79D848A2FB2CQ35115100-8F5E7873-54E5-44A0-B9D0-81C3F5200C04Q36042226-F3B2FE38-A6E4-4E8C-8AB9-75EF366B56C7Q36426658-32520890-4414-408C-922C-1F521E50FE4BQ37009096-E7492354-EC7D-4BB9-933E-1327124FBAB8Q38259728-758C92F9-7A85-4B57-A565-ADFA687F14B5Q38532386-BE27F27C-F438-42AC-902D-3041532FF615Q38663987-795320E6-B52D-47C7-95D4-64AF87326941Q38791718-5356868A-C90D-486E-85D8-DC28E9BE53FCQ38844387-0D6734CA-2191-4695-93E7-53AA7572EAFDQ38935425-79A8E61A-1052-416E-A97E-9ECBE5B7AF25Q38939270-6F775C3B-2DD6-4093-A00B-44D55FBEA960Q39272596-7E4C1039-114E-486A-AAD6-9667F9FC7B2DQ39548660-5B962E14-075C-43D1-9FB1-2EB0005FEC36Q40084324-9EDBECF0-D084-4DCC-8F29-2BE9B8D5AC8CQ40532663-6C88C105-AA6A-4DB4-8785-0CE9D4C9E710Q40533944-8ABA8DBA-264E-49C4-80B3-0353A7E0CCDDQ41072464-DE7479B7-CCAE-408C-B545-3A9D49E82924Q41282445-990645DB-B9AB-4BD1-930F-C0396D77B314Q42162484-097F9401-2887-49AF-942F-8485D56EDAA2Q42256610-84494C46-9DAB-4623-ACC7-4097A7BCE567Q43089781-BA7F378C-250F-4561-BC75-B1CD0CAB4C4EQ45073137-0D3313D1-7B46-46C1-89FD-60376A5B0762Q47428714-BB2A043D-3F43-4536-A346-C133914304ACQ47723607-D4A697E5-41F6-4C29-BBBF-996D3AC89D34Q48138983-D4C1ACA0-1F48-4D52-A913-1164BD32A6E5Q48628498-9EAFF05F-5928-4BA1-BE05-DD25509D544FQ50437078-5F336702-F721-48B5-BA34-2322DB45E963Q51692486-78472EEC-A507-489C-ACA9-867E807F01CDQ55224176-952CD06C-C6E3-416B-8211-6A934608E6DBQ55425790-4DE6AA34-54D8-4B91-9A69-8417400D6FCDQ57299899-21763481-FA9C-4FAB-AA7C-144620A41DB1Q58127823-F34F0830-1AE4-48BC-B8ED-459211412D29
P2860
Cardiac amyloidosis: updates in diagnosis and management.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cardiac amyloidosis: updates in diagnosis and management.
@ast
Cardiac amyloidosis: updates in diagnosis and management.
@en
Cardiac amyloidosis: updates in diagnosis and management.
@nl
type
label
Cardiac amyloidosis: updates in diagnosis and management.
@ast
Cardiac amyloidosis: updates in diagnosis and management.
@en
Cardiac amyloidosis: updates in diagnosis and management.
@nl
prefLabel
Cardiac amyloidosis: updates in diagnosis and management.
@ast
Cardiac amyloidosis: updates in diagnosis and management.
@en
Cardiac amyloidosis: updates in diagnosis and management.
@nl
P2093
P1476
Cardiac amyloidosis: updates in diagnosis and management.
@en
P2093
Dania Mohty
Danielle Casset-Senon
Najmeddine Echahidi
Patrice Virot
Pierre Cosnay
Thibaud Damy
P304
P356
10.1016/J.ACVD.2013.06.051
P577
2013-09-23T00:00:00Z